Amyloidosis in Cats: Causes, Symptoms & Treatment

Amyloidosis represents rare but profoundly serious disease affecting cats, characterised by abnormal misfolded proteins called amyloid accumulating progressively within vital organs tissues over time. Unlike normal proteins body can break down recycle, amyloid deposits cannot be eliminated by body's natural processes, instead remaining permanently lodged within organs disrupting their structure and function progressively. When amyloid accumulates within kidneys liver pancreas spleen gastrointestinal tract or other vital organs, it gradually compromises their ability function, eventually leading organ damage, organ failure, and life-threatening complications. Because amyloidosis develops gradually and early symptoms often vague resembling many other common feline illnesses, diagnosis frequently delayed until significant irreversible organ damage already occurred. Certain cat breeds particularly Abyssinian cats, Siamese cats, Oriental Shorthairs, Devon Rex, Burmese, and Tonkinese cats carry genetic predisposition developing familial hereditary amyloidosis, with genetics playing central role determining both disease development and which organs become primarily affected. Recent research increasingly recognises amyloidosis more commonly than previously thought, particularly shelter cat populations, suggesting disease may be more prevalent than historical literature suggested. Whilst cure does not currently exist, early diagnosis through appropriate testing, combined with supportive care and careful monitoring, can help improve quality of life slow disease progression, and extend survival time for cats diagnosed with this serious condition.

This comprehensive guide explains what amyloidosis is and why it develops, distinguishes between hereditary and secondary amyloidosis forms, identifies which cat breeds carry highest genetic risk, describes which organs are most commonly affected including breed-specific differences, explains detailed symptoms and clinical signs owners should recognise, outlines diagnostic procedures veterinarians use to confirm amyloidosis, discusses available treatment and management options, and provides guidance for home care and long-term support affected cats.

Understanding Amyloidosis in Cats

What Is Amyloidosis?

Amyloidosis occurs when abnormal misfolded proteins called amyloid accumulate progressively between cells within tissues and organs, progressively interfering normal organ function.

• Protein misfolding: Amyloid represents abnormally shaped protein that has lost normal three-dimensional structure
• Cannot be broken down: Unlike normal proteins, body lacks enzymes mechanisms effectively degrading breaking down amyloid
• Accumulates over time: Deposits build progressively within organs over months to years
• Disrupts function: As deposits expand, they physically interfere normal organ structure cellular function
• Multiple organ involvement possible: While kidneys and liver most common, amyloid can deposit pancreas, spleen, gastrointestinal tract, heart, other organs
• Progressive disease: Amyloidosis typically chronic progressive disorder worsening over time without effective reversal

How Amyloidosis Differs from Other Protein Diseases

• Permanent accumulation: Unlike conditions where abnormal proteins produced cleared from body, amyloid persists indefinitely
• Structural damage: Physical deposits cause direct tissue damage organ dysfunction
• Irreversible: Body cannot reabsorb or eliminate established amyloid deposits
• Progressive worsening: Even without additional amyloid formation, existing deposits cause increasing damage time

Types of Amyloidosis in Cats

Hereditary Familial Amyloidosis

Genetic form most commonly seen cats; inheritance patterns vary breed to breed.

• Genetic predisposition: Abnormal gene causes excessive amyloid production from birth
• Breed-specific patterns: Different breeds affected different organs; Abyssinians typically kidney involvement, Siamese/Oriental typically liver involvement
• Autosomal inheritance: Evidence suggests inheritance pattern though exact genetics still being researched
• Early onset possible: Hereditary cases may develop symptoms young as 1-4 years age, though typically middle-aged or older at diagnosis
• Breeding implications: Affected cats should removed from breeding programmes preventing transmission offspring

Secondary Amyloidosis

• Develops from chronic disease: Long-standing inflammation infection stimulates excessive amyloid production
• Chronic inflammation source: Persistent inflammatory conditions arthritis, chronic enteritis, other inflammatory disorders
• Chronic infection trigger: Long-term infections periodontitis, abscesses, systemic infections can trigger amyloid formation
• Immune-mediated diseases: Autoimmune conditions may increase amyloid production
• Less common cats: Secondary amyloidosis less frequently diagnosed cats compared hereditary forms

Idiopathic Amyloidosis

• Unknown cause: Many cats diagnosed amyloidosis without identifiable genetic breed predisposition underlying inflammatory condition
• Diagnosis challenge: Cannot definitively categorise without genetic testing or disease investigation

Which Cat Breeds Are Most Affected

Abyssinian and Somali Cats

• Kidney-primary involvement: Amyloid predominantly deposits within kidneys
• Genetic variants identified: Recent research identified six amyloidosis-associated genetic variants Abyssinian cats
• High prevalence historically: Disease particularly prevalent Abyssinian breed during 1980s-1990s, better recognised and managed currently
• Younger onset possible: Can develop early as young age though typically middle-aged older diagnosis
• Female predominance: Females appear slightly higher risk than males

Siamese and Oriental Shorthair Cats

• Liver-primary involvement: Amyloid predominantly deposits within liver
• Dangerous complications: Liver amyloidosis predisposes severe hepatic (liver) rupture bleeding
• Different genetics: Genetic variants Siamese cats differ significantly from Abyssinian variants despite both familial forms
• Early development: Hereditary Siamese amyloidosis may develop as early 1-4 years age
• Acute presentation: Often presents dramatically severe liver bleeding rather than gradual kidney disease

Other Predisposed Breeds

• Devon Rex: Increased amyloidosis risk documented
• Burmese cats: Increased predisposition noted
• Tonkinese cats: Familial form documented
• Random-bred cats: Disease can affect any cat breed, though less common

Organ Involvement and Clinical Presentation

Renal Amyloidosis (Kidney Disease)

Most common form; amyloid damages kidneys' filtering structures causing progressive kidney disease.

• Damage mechanism: Amyloid deposits in glomeruli (kidney's filtering units) disrupting filtration
• Protein loss: Damaged kidneys leak excessive protein urine (proteinuria)
• Progressive decline: Kidney function gradually deteriorates despite treatment
• Kidney failure risk: Disease progresses eventual kidney failure requiring intensive management
• Symptoms: Increased thirst, increased urination, weight loss, poor appetite, weakness, dehydration
• Lab findings: Elevated creatinine, blood urea nitrogen, proteinuria, azotemia
• Prognosis variable: Some cats survive several years, many less than one year post-diagnosis

Hepatic Amyloidosis (Liver Disease)

• Particularly Siamese Oriental breeds: Liver primary target organ Siamese Oriental Shorthairs
• Diffuse deposition: Amyloid accumulates throughout liver tissue
• Structural damage: Liver enlargement (hepatomegaly) or dysfunction
• Life-threatening bleeding: Liver amyloidosis predisposes liver lobe rupture spontaneous intra-abdominal haemorrhage
• Acute presentation: Cats may suddenly collapse from massive liver bleeding
• Symptoms: Jaundice (yellowing gums, skin), weakness, pale gums from blood loss, distended painful abdomen, rapid heart rate, breathing difficulty, vomiting, inappetence
• Emergency situation: Liver bleeding represents true medical emergency
• Grave prognosis: Liver-involved amyloidosis carries poorest prognosis; high mortality rate even with aggressive treatment

Other Organ Involvement

• Pancreatic amyloidosis: Can lead pancreatitis, diabetes complications
• Splenic deposits: Spleen can accumulate amyloid affecting its immune function
• Gastrointestinal involvement: Can cause chronic vomiting, diarrhoea, malabsorption
• Cardiac involvement: Rare but serious, can cause arrhythmias cardiac dysfunction

Symptoms of Amyloidosis in Cats

Early and Subtle Signs

• Often vague onset: Early symptoms often subtle resembling many other conditions
• Insidious progression: Symptoms develop gradually sometimes over months
• Easy to miss: Owners may not notice gradual changes until disease advanced
• Diagnosis delay result: Often significant organ damage already occurred before diagnosis made

Kidney Disease-Related Symptoms

• Increased thirst (polydipsia): Cat drinks noticeably more water
• Increased urination (polyuria): More frequent urination, larger volumes
• Weight loss: Gradual weight loss despite or despite normal appetite
• Poor appetite: Reduced interest food
• Lethargy: Decreased energy, sleeping more
• Weakness: Muscle weakness, reluctance activity
• Dehydration: Despite increased drinking, cats may appear dehydrated
• Poor coat condition: Dull, unkempt fur

Liver Disease-Related Symptoms

• Jaundice: Yellowing gums, white eyes, ears—indicates liver dysfunction
• Abdominal swelling: Distended swollen abdomen from fluid accumulation bleeding
• Acute collapse: Sudden severe weakness collapse from haemorrhage
• Pale gums: Pale or whitish gums indicating blood loss anaemia
• Rapid heart rate: Compensatory tachycardia from blood loss
• Difficult breathing: Rapid shallow breathing
• Vomiting: Persistent vomiting from liver dysfunction
• Inappetence: Complete loss appetite
• Abdominal pain: Reluctance allow abdominal touch

Other Possible Symptoms

• Fever: Sometimes present, particularly if secondary chronic inflammation
• Vomiting diarrhoea: Gastrointestinal involvement
• Blood clotting abnormalities: Liver disease affects clotting factors

Diagnosis of Amyloidosis

Clinical Suspicion

Diagnosis suspected based breed, age, symptoms, test results suggesting kidney liver disease.

• Breed history important: Abyssinian, Siamese, Oriental Shorthair, other predisposed breeds raised suspicion
• Clinical signs: Chronic kidney or liver disease signs may suggest amyloidosis
• Age at presentation: Both young hereditary cases older cats can develop disease

Blood and Urine Testing

• Complete blood count: May show anaemia indicating blood loss or chronic disease
• Blood chemistry profile: Shows kidney function (elevated creatinine, BUN), liver function (elevated enzymes, bilirubin)
• Urinalysis: Detects proteinuria (protein urine)—hallmark kidney amyloidosis
• Urine protein quantification: Measures degree proteinuria
• Coagulation tests: May abnormal liver amyloidosis
• Serum amyloid A (SAA): Acute phase protein; elevated SAA may support amyloidosis suspicion though not definitive

Imaging

• Ultrasound: Can identify kidney changes, liver changes, verify organ involvement
• X-rays: Supportive imaging identifying associated findings
• May show: Kidney size changes, liver enlargement, abdominal fluid, evidence liver bleeding

Definitive Diagnosis: Tissue Biopsy

Biopsy remains gold standard definitive diagnosis; requires special staining confirmation.

• Kidney biopsy: Obtained needle aspiration or surgical biopsy
• Liver biopsy: May obtained similarly though carries higher risk liver disease
• Congo red staining: Gold standard staining method highlighting amyloid deposits
• Polarised light microscopy: Shows characteristic apple-green birefringence under polarised light confirming amyloid
• Immunohistochemistry: Further characterises amyloid type (AA vs AL)
• Risk-benefit consideration: Biopsy carries procedural risk particularly liver disease; veterinarian carefully considers whether biopsy necessary diagnosis confirmation
• Aspiration cytology: Sometimes amyloid fibrils retrieved needle aspirate confirming diagnosis without full biopsy

Treatment and Management

No Cure Exists

Currently, no treatment removes existing amyloid deposits or prevents complete disease progression.

Supportive Management Approach

• Primary goal: Slowing disease progression, managing complications, maintaining quality life
• Individualised approach: Treatment tailored based organ involvement, disease severity, overall health

Kidney Disease Management

• Prescription renal diet: Specially formulated reduced protein, phosphorus, sodium appropriate kidney disease
• Fluid therapy: Intravenous or subcutaneous fluids stabilise cats severe kidney disease
• Blood pressure control: Medications (ACE inhibitors, calcium channel blockers) managing hypertension protecting remaining kidney function
• Medications reducing proteinuria: Drugs like ACE inhibitors decreasing urinary protein loss
• Phosphate binders: Managing hyperphosphataemia kidney disease
• Anti-nausea medication: Managing uraemia-related nausea improving appetite
• Appetite stimulants: Helping maintain nutrition

Liver Disease Management

• Supportive care only: No specific medical treatment removes hepatic amyloid
• Emergency management: Immediate intervention required case liver rupture bleeding (blood transfusion, aggressive fluid therapy)
• Monitoring closely: Regular monitoring for signs acute bleeding
• Activity restriction: Limiting activity reducing risk liver trauma rupture

Treating Underlying Conditions

• Secondary amyloidosis focus: If chronic infection inflammation identified underlying cause, treating condition may slow additional amyloid formation
• Anti-inflammatory therapy: Managing chronic inflammatory diseases reducing continued amyloid production
• Infection treatment: Aggressive treatment chronic infections

Experimental or Emerging Therapies

• Colchicine research: Some studies exploring colchicine reducing amyloid production; evidence limited cats
• No proven effectiveness: No universally accepted medication successfully halting amyloidosis cats

Home Care and Monitoring

Dietary Management

• Follow veterinary recommendations: Feed only prescribed renal diet maintaining appropriate protein phosphorus levels
• Consistency important: Maintain consistent diet avoiding unapproved treats
• Appetising food: Warming food moistening may encourage eating decline

Medication Administration

• Consistent dosing: Administer medications exactly prescribed schedule
• Regular monitoring: Attend all scheduled vet appointments blood work monitoring

Hydration Support

• Fresh water access: Constant availability fresh water essential
• Multiple water sources: Multiple bowls throughout home encourage drinking
• Water fountains: Some cats prefer flowing water fountains

Activity and Stress Management

• Avoid strenuous activity: Particularly liver involvement, restrict activity
• Stress reduction: Calm quiet environment minimising stress
• Comfortable spaces: Provide comfortable resting areas accessible litter boxes

Monitoring and Observation

• Appetite monitoring: Watch eating patterns appetite changes
• Thirst urination: Monitor drinking frequency, urine colour volume
• Weight tracking: Regular weighing monitoring weight loss stability
• Vomiting diarrhoea: Note any gastrointestinal symptoms
• Abdominal changes: Watch swelling, pain, distension (particularly liver disease)
• Collapse signs: Immediately report any weakness, collapse, difficulty breathing
• Regular blood work: Frequent monitoring (every 2-4 weeks initially, then 3-6 months) essential tracking disease progression

Prognosis and Life Expectancy

Variable Depending on Organ Involvement

• Renal amyloidosis: Many cats survive less than one year after diagnosis; some survive several years appropriate management
• Hepatic amyloidosis: Much poorer prognosis; high mortality rates particularly following liver rupture bleeding

Factors Affecting Prognosis

• Organ involved: Liver involvement carries worse prognosis than kidney involvement alone
• Extent amyloid: Amount amyloid deposits extent organ damage influences outcome
• Disease stage at diagnosis: Earlier detection generally better outcomes
• Overall health: Concurrent health problems worsen prognosis
• Owner commitment: Dedicated management monitoring may extend survival quality of life

Prevention and Breeding Considerations

Hereditary Forms Cannot Be Prevented

• Genetic inheritance: Affected cats cannot avoid passing genetic predisposition offspring
• Breeding recommendations: Affected cats should removed breeding programmes
• Genetic testing: New genetic variants identified; responsible breeders increasingly using genetic testing selecting healthier animals

Reducing Secondary Amyloidosis Risk

• Manage chronic disease: Prompt treatment chronic infections inflammation
• Dental care: Regular dental check-ups preventing chronic infections
• Regular vet care: Routine examinations detecting early disease
• Maintain health: Good nutrition, exercise, stress reduction supporting overall health

When to Contact Your Veterinarian

• Predisposed breeds: Abyssinian, Siamese, Oriental cats should have regular screening blood work
• New symptoms: Increased thirst, urination, weight loss, poor appetite, weakness, lethargy
• Liver disease signs: Jaundice, vomiting, abdominal distension, pale gums
• Sudden collapse: Emergency veterinary care immediately
• Abnormal blood work: Elevation creatinine, BUN, proteinuria warrants investigation
• Existing diagnosis: All scheduled monitoring appointments critical tracking disease

This guide is based on research from PetMD, VCA Animal Hospitals, Merck Veterinary Manual, Ask A Vet, Journal of Veterinary Internal Medicine 2024 study, EveryCat Health Foundation genetic research, Feline Genetics Comparative Medicine Laboratory University Missouri, Vet Help Direct. Amyloid composition: consists misfolded protein fibrils; AA amyloidosis (from serum amyloid A) most common cats, AL amyloidosis (plasma cell-derived) rare. Congo red staining: gold standard histological confirmation; amyloid shows characteristic brick-red colour under light microscopy, apple-green birefringence under polarised light. Serum amyloid A: acute phase protein elevated chronic inflammation infection; elevated SAA supports but does not diagnose amyloidosis. Genetic variants: Abyssinian six variants identified; Siamese variants differ suggesting separate genetic causes despite both familial forms. Shelter cat prevalence: Italian study found high prevalence shelter cats, associated azotemia proteinuria, suggesting disease more common particularly certain populations. Breed-specific target organs: Abyssinian primarily kidney (renal AA amyloidosis), Siamese Oriental primarily liver (hepatic amyloidosis), other breeds variable; suggests different genetic mechanisms. Liver rupture risk: Siamese Oriental amyloidosis predisposes hepatic rupture bleeding life-threatening emergency. Progressive nature: disease continues worsening despite treatment; no reversal established amyloid deposits. Colchicine use: some limited evidence suggesting reduction amyloid production; not universally recommended. Female predominance: evidence suggests female cats slightly higher risk than males, particularly Abyssinian breed. Age variability: hereditary cases may develop 1-4 years age (particularly Siamese), though most diagnosis middle-aged to older cats.